Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of €318.12 million as of December 5, 2025. Its market cap has increased by 94.81% in one year.

Market Cap

318.12M

Enterprise Value

418.47M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

€4.84

Market Cap Chart

Since September 4, 2002, Galectin Therapeutics's market cap has increased from 31.76M to 318.12M, an increase of 901.77%. That is a compound annual growth rate of 10.41%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	318.12M	306.79%
Dec 31, 2024	78.20M	-15.81%
Dec 29, 2023	92.88M	47.83%
Dec 30, 2022	62.83M	-41.83%
Dec 31, 2021	108.01M	3.34%
Dec 31, 2020	104.52M	-27.91%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	248.18B
Siemens Aktiengesellschaft	179.36B
Allianz SE	139.47B
Deutsche Telekom AG	130.38B
Siemens Energy AG	99.98B
Rheinmetall AG	70.66B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.26B
Deutsche Bank Aktiengesellschaft	59.33B

Market Cap Rankings